Feedback Suppression of PI3Kα Signaling in PTEN-Mutated Tumors Is Relieved by Selective Inhibition of PI3Kβ-Reference-Cited by-同舟云学术

Feedback Suppression of PI3Kα Signaling in PTEN-Mutated Tumors Is Relieved by Selective Inhibition of PI3Kβ

Published:2015-01 Issue:1 Volume:27 Page:109-122
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Schwartz Sarit,Wongvipat John,Trigwell Cath B.,Hancox Urs,Carver Brett S.,Rodrik-Outmezguine Vanessa,Will Marie,Yellen Paige,de Stanchina Elisa,Baselga José,Scher Howard I.,Barry Simon T.,Sawyers Charles L.,Chandarlapaty Sarat,Rosen Neal

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference44 articles.

1. A phase II trial of temsirolimus in men with castration-resistant metastatic prostate cancer;Armstrong;Clin. Genitourin. Cancer,2013

2. Characterization of the mechanism of action of the pan class I PI3K inhibitor NVP-BKM120 across a broad range of concentrations;Brachmann;Mol. Cancer Ther.,2012

3. Comprehensive molecular portraits of human breast tumours;Cancer Genome Atlas;Nature,2012

4. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer;Carracedo;J. Clin. Invest.,2008

5. Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer;Carver;Cancer Cell,2011

Cited by 206 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting PI3K family with small-molecule inhibitors in cancer therapy: current clinical status and future directions;Molecular Cancer;2024-08-10

2. Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial;European Journal of Cancer;2024-07

3. Resistance to Targeted Inhibitors of the PI3K/AKT/mTOR Pathway in Advanced Oestrogen-Receptor-Positive Breast Cancer;Cancers;2024-06-18

4. Gedatolisib shows superior potency and efficacy versus single-node PI3K/AKT/mTOR inhibitors in breast cancer models;npj Breast Cancer;2024-06-05

5. Comprehensive Review on Recent Strategies for Management of Prostate Cancer: Therapeutic Targets and SAR;Mini-Reviews in Medicinal Chemistry;2024-04